SRD5A3 Gene Congenital disorder of glycosylation type Iq Genetic Test sale cost 4400 AED
GFM1 Gene Combined oxidative phosphorylation deficiency type 1 Genetic Test sale cost 3200 AED GFM1 Gene Combined oxidative phosphorylation deficiency type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.3,200 د.إCurrent price is: 3,200 د.إ.
AVP Gene Diabetes insipidus neurohypophyseal Genetic Test sale cost 4400 AED AVP Gene Diabetes insipidus neurohypophyseal Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SRD5A3 Gene Congenital disorder of glycosylation type Iq Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SRD5A3 gene congenital disorder of glycosylation type Iq genetic test is a specialized diagnostic tool available at DNA Labs UAE. This genetic test is designed to identify mutations in the SRD5A3 gene, which are associated with Congenital Disorder of Glycosylation Type Iq (CDG-Iq), a rare genetic condition. CDG-Iq affects the normal process of glycosylation, which is critical for the proper function of various proteins and lipids in the body. Symptoms of CDG-Iq can vary widely among individuals but may include developmental delay, intellectual disability, vision problems, and abnormalities in liver function.

The test is performed using a blood sample from the patient, which is then analyzed using advanced genetic sequencing techniques to detect any mutations in the SRD5A3 gene. This precise genetic testing allows for an accurate diagnosis of CDG-Iq, enabling healthcare providers to tailor treatment and management plans to the specific needs of the patient.

The cost of the SRD5A3 gene congenital disorder of glycosylation type Iq genetic test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and the detailed information it provides, it represents a crucial step towards understanding and managing this rare genetic disorder. Early diagnosis through this genetic test can significantly impact the quality of life for individuals with CDG-Iq by facilitating early interventions and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SRD5A3 Gene Congenital Disorder of Glycosylation Type Iq Genetic Test

Components

  • Test Name: SRD5A3 Gene Congenital Disorder of Glycosylation Type Iq Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for SRD5A3 Gene Congenital Disorder of Glycosylation, Type Iq NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Congenital Disorder of Glycosylation, Type Iq

Test Details

The SRD5A3 gene is associated with a congenital disorder of glycosylation, specifically type Iq (CDG-Iq). CDG-Iq is a rare genetic disorder that affects the glycosylation process, which is responsible for attaching sugar molecules to proteins and lipids. This gene provides instructions for making an enzyme called steroid 5-alpha-reductase 3, which is involved in the production of certain hormones.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. It can identify variations or mutations in the SRD5A3 gene that may be associated with CDG-Iq.

Genetic testing for CDG-Iq can help in diagnosing the condition, predicting the severity of symptoms, and guiding treatment options. It can also provide valuable information for genetic counseling and family planning.

It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of genetic testing before undergoing any testing procedure.

Test Name SRD5A3 Gene Congenital disorder of glycosylation type Iq Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SRD5A3 Gene Congenital disorder of glycosylation, type Iq NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Congenital disorder of glycosylation, type Iq
Test Details

The SRD5A3 gene is associated with a congenital disorder of glycosylation, specifically type Iq (CDG-Iq). CDG-Iq is a rare genetic disorder that affects the glycosylation process, which is responsible for attaching sugar molecules to proteins and lipids. This gene provides instructions for making an enzyme called steroid 5-alpha-reductase 3, which is involved in the production of certain hormones.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. It can identify variations or mutations in the SRD5A3 gene that may be associated with CDG-Iq.

Genetic testing for CDG-Iq can help in diagnosing the condition, predicting the severity of symptoms, and guiding treatment options. It can also provide valuable information for genetic counseling and family planning.

It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of genetic testing before undergoing any testing procedure.

SKU: TEST-2260 Category:

Related products